Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

An interdisciplinary team of engineers and medics is addressing ways to increase the UK's capacity for ventilator manufacture.

OxVent ventilator
The OxVent prototype ventilator could save thousands of lives if approved for mass production

Engineers, anaesthetists and surgeons from the University of Oxford and King's College London are working together to build and test prototypes that can be manufactured using techniques and tools available in well-equipped university and small and medium enterprise (SME) workshops.

"I spoke to my DPhil supervisor Professor Mark Thompson about the need for ventilators two weeks ago and suggested a cross department collaboration to build a rapid prototype ventilator for COVID-19. Things have been moving rapidly," said DPhil student Rob Staruch.

"Within a week we had a working prototype and we have presented the ventilator to the Cabinet Office."

The OxVent is an incredibly simple device based on an Ambu (artificial manual breathing unit) bag. A mask connects to a rubber bag that inflates and deflates as it pushes air into the patients' lungs. It resembles the devices used by paramedics to resuscitate people where the bags are pumped by hand. The OxVent device houses the Ambu or bag valve mask within a rigid perspex box which can be pressurised, compressing the Ambu and providing an inhalation. When the pressure is switched off, the Ambu re-inflates. The patient receives air, which can be mixed with oxygen, through a tube leading from the bag.

The design aims to exploit off-the-shelf components and equipment already held by the NHS and SMEs and reduce any pressures on the supply chains that may already be challenged by the coronavirus. The design strategy was simplicity: to have very few moving parts that had the potential to go wrong, and to minimise costs. The team thinks the OxVent can be produced a cost of less than £1,000 and, as well as the academic support that's been forthcoming, they have already heard from industry offering fabrication, 3D printing and other processes to support production.

Professor Farmery, Oxford's Nuffield Department of Clinical Neurosciences, says: "Ordinarily, to develop a medical device such as this would be a huge task, and would take years. We have designed a simple and robust ventilator which will serve the specific task of managing the very sickest patients during this crisis.

"By pooling available expertise from inside and outside the University, and making the design freely available to local manufacturers, we are pleased to be able to respond to this challenge so quickly."

Professor Thompson, Associate Professor in Engineering Science at the University of Oxford said: "This extraordinary situation demands an extraordinary response and we are pulling all the talents together in an exceptional team combining decades of experience translating research into the clinic, brilliant innovators, and highly skilled technicians."

Find out more on the project website: https://oxvent.org/

 

Similar stories

Immunology preprint reviews launched in Nature Reviews Immunology

Kennedy Main Research

The Oxford-Mount Sinai (OxMS) Preprint Journal Club has partnered with Nature Reviews Immunology to launch a monthly Preprint Watch column.

A more tailored approach to treating psoriatic arthritis

Arthritis Botnar Funding Main

Dr Laura Coates has been awarded £1.8M from the National Institute for Health Research (NIHR) to explore the potential for precision medicine in the choice of biologics to reduce inflammation and pain in psoriatic arthritis.

Motion-capture to help children walk: Oxford team support new gait laboratory in Ethiopia

Main Orthopaedics and trauma

The Research at Oxford on Analysis of Motion (ROAM) team at the University of Oxford have supported CURE Ethiopia Children’s Hospital to develop and open a brand new gait laboratory, the first of its kind in the country and the only other active gait lab on the African continent outside of South Africa.

Professor Eleanor Stride recognised in New Year’s Honours list 2021

Awards Main

Statutory Professor of Biomaterials is awarded Officer of the Order of the British Empire (OBE) for services to Engineering

Drug may boost vaccine responses in older adults

Kennedy Main

A preliminary study shows that a drug which helps immune cells self-clean may improve vaccine protection in older adults

Living reviews launched by Oxford and Cardiff in the wake of COVID-19 research

Kennedy Main Research

In a combined effort to help COVID-19 researchers the University of Oxford and Cardiff University have launched a series of “living reviews” in Oxford University Press’s new open access journal “Oxford Open Immunology”.